Cargando…

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply

Detalles Bibliográficos
Autores principales:	Colhoun, Helen M, McGurnaghan, Stuart J, McKeigue, Paul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963445/ https://www.ncbi.nlm.nih.gov/pubmed/33740437 http://dx.doi.org/10.1016/S2213-8587(21)00055-3

Ejemplares similares

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics
por: Iakovliev, Andrii, et al.
Publicado: (2023)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study
por: Ochs, Andreas, et al.
Publicado: (2019)

Biomarker panels associated with progression of renal disease in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2019)

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
por: Colombo, Marco, et al.
Publicado: (2019)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study
por: Bell, Samira, et al.
Publicado: (2017)

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers
por: Valo, Erkka, et al.
Publicado: (2022)

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2020)

Development and validation of a cardiovascular risk prediction model in type 1 diabetes
por: McGurnaghan, Stuart J., et al.
Publicado: (2021)

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study
por: McKeigue, Paul M., et al.
Publicado: (2020)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland
por: McGurnaghan, Stuart J., et al.
Publicado: (2022)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018
por: Höhn, Andreas, et al.
Publicado: (2022)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

Authors’ reply
por: Rigby, David, et al.
Publicado: (2020)

Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study
por: Jeyam, Anita, et al.
Publicado: (2021)

Microvascular disease in diabetes and severe COVID-19 outcomes
por: Corcillo, Antonella, et al.
Publicado: (2021)

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
por: McKeigue, Paul M, et al.
Publicado: (2022)

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
por: Vadiveloo, Thenmalar, et al.
Publicado: (2018)

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
por: O’Reilly, Joseph E., et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
por: Jeyam, Anita, et al.
Publicado: (2021)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
por: McKeigue, Paul M., et al.
Publicado: (2019)

COVID-19 and maternal and perinatal outcomes – Authors' reply
por: Chmielewska, Barbara, et al.
Publicado: (2021)

Host or pathogen-related factors in COVID-19 severity? – Authors' reply
por: Okell, Lucy C, et al.
Publicado: (2020)

Authors’ Reply
por: Reddy, Raghunatha R, et al.
Publicado: (2012)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Authors' Reply
por: Tian, Di, et al.
Publicado: (2022)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

Prone positioning might reduce the need for intubation in people with severe COVID-19 – Authors' reply
por: Ibarra-Estrada, Miguel, et al.
Publicado: (2021)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

Author's Reply
por: Kaeberlein, Matt, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_h7m6heeuk68k6lns0nph1rnos4